Detection of dengue virus serotype 1 from gadfly in China
Dear Editor, (Source: Journal of Infection)
Source: Journal of Infection - July 10, 2023 Category: Infectious Diseases Authors: Nan-Shan Qi, Xu Zhang, Shen-Quan Liao, Juan Li, Ju-Mei Liu, Jian-Wei Shao, Ming-Fei Sun Source Type: research
Long Covid: Potential Role of the Reactive Species Interactome
Dear Editor, (Source: Journal of Infection)
Source: Journal of Infection - July 10, 2023 Category: Infectious Diseases Authors: Martin Feelisch, Anna D Clark, Andrew F Cumpstey, J érôme Santolini, Alan A Jackson Source Type: research
Prolonged vs short-term infusion of β-lactam antibiotics for the treatment of febrile neutropenia: a systematic review and meta-analysis
The optimization of the use of β-lactam antibiotics (BLA) via prolonged infusions in life-threatening complications such as febrile neutropenia (FN) is still controversial. This systematic review and meta-analysis aim to evaluate the efficacy of this strategy in onco-haematological patients with FN. (Source: Journal of Infection)
Source: Journal of Infection - July 7, 2023 Category: Infectious Diseases Authors: J Laporte-Amargos, M Ulldemolins, M Puig-Asensio, C Teb é, S Castro, J Carratalà, C. Gudiol Source Type: research
Influence of a chronic Schistosoma mansoni infection on the outcomes of a SARS-CoV-2 infection in the hamster model
Dear Sir, (Source: Journal of Infection)
Source: Journal of Infection - July 5, 2023 Category: Infectious Diseases Authors: Melanie Rissmann, Edwin J.B. Veldhuis Kroeze, Aloysius G.M. Tielens, Barry Rockx, Jaap J. van Hellemond Source Type: research
Evaluation of the neutralizing antibody response against the omicron variant produced by heterologous or hybrid immunity: how does the fifth dose of COVID-19 vaccine affect the neutralizing antibody response?
Dear Editor, (Source: Journal of Infection)
Source: Journal of Infection - July 4, 2023 Category: Infectious Diseases Authors: G ülsüm İclal BAYHAN, Rahmet GÜNER, Aysun YAHŞİ, Aykut ÖZKUL Source Type: research
Safety and Immunogenicity against Ancestral, Delta and Omicron Virus Variants Following a Booster Dose of an Inactivated Whole-Virus COVID-19 Vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial
Booster doses for COVID-19 vaccinations have been shown to amplify the waning immune response after primary vaccination and to enhance protection against emerging variants of concern (VoCs). Here, we aimed to assess the immunogenicity and safety of a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001) after primary vaccination with 2 doses of either VLA2001 or ChAdOx1-S (Oxford-Astra Zeneca), including the cross-neutralization capacity against the Delta and Omicron VoCs. (Source: Journal of Infection)
Source: Journal of Infection - July 3, 2023 Category: Infectious Diseases Authors: Christian Taucher, Rajeka Lazarus, Hanna Dellago, Gabriele Maurer, Petronela Weisova, Irena Corbic-Ramljak, Katrin Dubischar, Anders Lilja, Susanne Eder-Lingelbach, Romana Hochreiter, Juan Carlos Jaramillo, Helga Junker, Michael Krammer, Petra Pusic, Bene Source Type: research
Whole-genome sequencing reveals widespread presence of Staphylococcus capitis NRCS-A clone in neonatal units across the United Kingdom
Increased incidence of neonatal Staphylococcus capitis bacteraemia in summer 2020, London, raised suspicion of widespread multidrug-resistant clone NRCS-A. We set out to investigate the molecular epidemiology of this clone in neonatal units (NNUs) across the UK. (Source: Journal of Infection)
Source: Journal of Infection - June 29, 2023 Category: Infectious Diseases Authors: Yu Wan, Mark Ganner, Zaynab Mumin, Derren Ready, Ginny Moore, Isabelle Potterill, Karthik Paranthaman, Elita Jauneikaite, Bharat Patel, Alessandra Harley, Maria Getino, UKHSA S. capitis Incident Management Team, Colin S. Brown, Alicia Demirjian, Bruno Pic Source Type: research
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiologic agent of the Coronavirus Disease 19 (COVID-19), has been progressively adapting to the human host since the beginning of the epidemic1. The Omicron variant, first identified in South Africa in November 2021, is the best adapted variant of concern (VOC), combining highly efficient binding to the ACE-2 cell receptor and immune escape. Since its emergence, Omicron has evolved into a plethora of descendant sublineages, including BA.1, BA.2, BA.3, BA.4, and BA.5. (Source: Journal of Infection)
Source: Journal of Infection - June 29, 2023 Category: Infectious Diseases Authors: Ilenia Varasi, Alessia Lai, Lia Fiaschi, Annalisa Bergna, Antonella Gatti, Barbara Caimi, Camilla Biba, Carla della Ventura, Claudia Balotta, Agostino Riva, Gianguglielmo Zehender, Maurizio Zazzi, Ilaria Vicenti Tags: Letter to the Editor Source Type: research
The association between zinc deficiency, and clinical outcomes of COVID-19
Dear Editor, (Source: Journal of Infection)
Source: Journal of Infection - June 29, 2023 Category: Infectious Diseases Authors: Jheng-Yan Wu, Wan-Hsuan Hsu, Ya-Wen Tsai, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang, Szu-En Chin, Chih-Cheng Lai, Mei-Yuan Liu Tags: Letter to the Editor Source Type: research
Nucleocapsid-Specific Antibodies as a Correlate of Protection against SARS-CoV-2 Reinfection in Children
SARS-CoV-2 infection confers relative protection against reinfection, albeit short-term and incomplete,1 and improved immune correlates and vaccine approaches are required to reduce the prevalence of reinfection. Spike-specific antibody titres associate with protection in adults2 whilst both infection3 and vaccination were protective in children during the initial phases of the pandemic.4 However, the omicron variant shows increased infectivity and protection afforded by ancestral-spike based vaccines has diminished markedly. (Source: Journal of Infection)
Source: Journal of Infection - June 28, 2023 Category: Infectious Diseases Authors: Alexander C. Dowell, Dagmar Waiblinger, John Wright, Shamez N. Ladhani, Paul Moss Source Type: research
Genomic characteristics of SARS-CoV-2 variants and their clinical impact on patients with COVID-19 in Taiwan
Dear Editor, (Source: Journal of Infection)
Source: Journal of Infection - June 26, 2023 Category: Infectious Diseases Authors: Hung-Chieh Su, Zi-Lun Lai, Yu-Chang Chang, Meng-Yu Cheng, Wen-Hsin Hsih, Yi-Jhen Chen, Chia-Huei Chou, Chieh-Lung Chen, Yu-Chao Lin, Tsai-Hsiu Lin, Chiung-Tzu Hsiao, Mao-Wang Ho, Hong-Mo Shih, Po-Ren Hsueh, Der-Yang Cho Source Type: research
Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in a remote region of Niger
Whole genome sequencing (WGS) of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-E. coli) in developing countries is lacking. Here we describe the population structure and molecular characteristics of ESBL-E. coli faecal isolates in rural Southern Niger. (Source: Journal of Infection)
Source: Journal of Infection - June 25, 2023 Category: Infectious Diseases Authors: Herv é Jacquier, Bachir Assao, Françoise Chau, Ousmane Guindo, Bénédicte Condamine, Mélanie Magnan, Antoine Bridier-Nahmias, Nathan Sayingoza-Makombe, Aissatou Moumouni, Anne-Laure Page, Céline Langendorf, Matthew E Coldiron, Erick Denamur, Victoire Source Type: research
Asymptomatic Plasmodium falciparum infection evades triggering a host transcriptomic response
Dear Editor, (Source: Journal of Infection)
Source: Journal of Infection - June 23, 2023 Category: Infectious Diseases Authors: Diana Ahu Prah, Claire Dunican, Linda Eva Amoah, Mahdi Moradi Marjaneh, Myrsini Kaforou, Asa Nordgren, William Jones-Warner, Yaw Aniweh, Gordon A Awandare, Aubrey J Cunnington, Julius Clemence R Hafalla Tags: Letter to the Editor Source Type: research
Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis
Historically, extensively drug-resistant tuberculosis has been notoriously difficult to treat with devasting outcomes. As we are coming to the end of an era where the 2006 extensively drug-resistant tuberculosis definitions and old treatment regimens are being replaced, we aimed to estimate the proportion of extensively drug-resistant tuberculosis patients globally who achieved successful treatment outcomes. (Source: Journal of Infection)
Source: Journal of Infection - June 22, 2023 Category: Infectious Diseases Authors: Ole Skouvig Pedersen, Freja Breth Holmgaard, Mads Kristian Duborg Mikkelsen, Christoph Lange, Giovanni Sotgiu, Troels Lillebaek, Aase Bengaard Andersen, Christian Morberg Wejse, Victor Naestholt Dahl Source Type: research
Genomic Characterization of a Newly Emerging Circulating Recombinant Form of HIV-1, CRF143_cpx, Involving Subtypes B, C and CRF01_AE, Identified in Yunnan, China
Dear Editor: (Source: Journal of Infection)
Source: Journal of Infection - June 22, 2023 Category: Infectious Diseases Authors: Meilan He, Chongxi Li, Wei Chang, Bo Tian, Yang Liu, Li Liu, Jun Liu, Yue Feng Tags: Letter to the Editor Source Type: research
